• Special Issue Topic
    Exploring Type 2 Diabetes Mellitus
    Submission Deadline: July 30, 2020

    Guest Editors

    Dr. Alessandro Mantovani E-Mail

    Assistant Professor, Section of Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy

    Research Keywords: type 2 diabetes and risk of cardiovascular complications; type 2 diabetes and risk of diabetic foot complications

    Dr. Giovanni Targher E-Mail

    Associate Professor, Section of Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy

    Research Keywords: type 2 diabetes and risk of chronic vascular complications of diabetes; role of nonalcoholic fatty liver disease in diabetes

    About the Special Issue

    Type 2 diabetes mellitus is a major public health problem that has reached epidemic proportions worldwide. Type 2 diabetes mellitus is also strongly associated with serious chronic complications, including ischemic heart disease, stroke, blindness, kidney disease and lower-extremity amputations leading to disability and early mortality. From 1980 to 2014, the number of people affected by type 2 diabetes mellitus almost quadrupled from 108 million to 422 million worldwide, showing a growth in the global prevalence from 4.7% to 8.5%. This growth trend is not estimated to slow in the near future. Indeed, according to the recent estimates from the International Diabetes Federation, the prevalence of the disease is expected to further increase to 9.9% by the year 2045 with an estimated population of around 640 million people with diabetes worldwide. This undoubtedly represents a potential future healthcare crisis for patients and providers alike. Areas of ongoing research include all aspects of type 2 diabetes mellitus, including epidemiology, physiopathology, risk factors, complications, management and treatment.

    Keywords: type 2 diabetes; chronic complications; epidemiology; management; pharmacologic treatment; risk factors

    Call for Papers

    Published Articles

    Open Access
    Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?
    Technology in diabetes is rapidly evolving, with the aim of helping affected people to safely optimize their blood glucose control. New technologies are now considered as an essential tool for manag...
    Erika Pedone ... Amelia Caretto
    Published: October 30, 2020 Explor Med. 2020;1:314-330
    DOI: https://doi.org/10.37349/emed.2020.00021
    Times Cited: 0
    Open Access
    Type 2 diabetes and cancer: problems and suggestions for best patient management
    Diabetes and cancer are widespread worldwide and the number of subjects presenting both diseases increased over the years. The management of cancer patients having diabetes represents a challenge no...
    Agostino Milluzzo ... Laura Sciacca
    Published: August 31, 2020 Explor Med. 2020;1:184-204
    DOI: https://doi.org/10.37349/emed.2020.00013
    Times Cited: 0
    Open Access
    GLP-1 receptor agonists for NAFLD treatment in patients with and without type 2 diabetes: an updated meta-analysis
    Aim: Recent randomized controlled trials (RCTs) have tested the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RA) to specifically treat non-alcoholic fatty liver disease (NAFLD). We ...
    Alessandro Mantovani ... Giovanni Targher
    Published: June 29, 2020 Explor Med. 2020;1:108-123
    DOI: https://doi.org/10.37349/emed.2020.00008